Intracellular association of a mutant insulin-like growth factor receptor with endogenous receptors

Clinical Cancer Research

Volumn 7, Issue 7, 2001, Pages 2134-2144

  Reiss, K ^a   Tu, X ^a   Romano, G ^a   Peruzzi, F ^a   Wang, J Y ^a   Baserga, R ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN 70; MUTANT PROTEIN; SOMATOMEDIN C RECEPTOR;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL GROWTH; CELL SURVIVAL; CELL TYPE; CONTROLLED STUDY; DROSOPHILA MELANOGASTER; DRUG MECHANISM; DRUG UPTAKE; EXPRESSION VECTOR; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LONG TERMINAL REPEAT; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; RETROVIRUS;

AGAR; ANIMALS; APOPTOSIS; CELL COUNT; CELL DIVISION; CELL LINE; CULTURE MEDIA, CONDITIONED; GENE EXPRESSION; GENOTYPE; MICROSCOPY, CONFOCAL; MUTATION; PLASMIDS; PROTEIN BINDING; RECEPTOR, IGF TYPE 1; RECOMBINANT FUSION PROTEINS;

EID: 0034772879     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. The price of independence
2. IGFscell growth
3. IGF-I receptor function: Transducing the IGF-I signal into intracellular events
4. Loss of tumorigenicity of rat glioblastoma directed by episome-based antisense cDNA transcription of insulin-like growth factor 1
5. Rat glioblastoma cells expressing an antisense RNA to the insulin-like growth factor 1 (IGF-1) receptor are non-tumorigenic and induce regression of wild-type tumors
6. Correlation between apoptosis, tumorigenesis and levels of insulin-like growth factor 1 receptors
7. Antisense-mediated reduction in insulin-like growth factor 1 receptor expression suppresses the malignant phenotype of a human alveolar rhabdomyosarcoma
8. Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor 1 receptor antisense ribonucleic acid
9. Inhibition of insulin-like growth factor 1 receptor expression in neuroblastoma cells induces the regression of established tumors in mice
10. Antisense phosphorothioate oligodeoxynucleotide down-regulation of the insulinlike growth factor 1 receptor in ovarian cancer cells
11. Down-regulation of the insulin-like growth factor 1 receptor by antisense RNA can reverse the transformed phenotype of human cervical cancer cell lines
12. Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor receptor mutant
13. A soluble insulin-like growth factor 1 receptor that induces apoptosis of tumor cells in vivo and inhibits tumorigenesis
14. Suppression of insulin-like growth factor 1 receptor by a triple-helix strategy inhibits IGF-1 transcription and tumorigenic potential of rat C6 glioblastoma cells
15. Loss of the metastatic phenotype in murine carcinoma cells expressing an antisense RNA to the insulin-like growth factor 1 receptor
16. Antisense RNA to the type 1 insulin-like growth factor receptor suppresses tumor growth and prevents invasion by rat prostate cancer cells in vivo
17. A dominant negative mutant of the insulin-like growth factor 1 receptor inhibits the adhesion, invasion and metastasis of breast cancer
18. Insulin-like growth factors and cancer
19. The effects of insulin-like growth factors on tumorigenesis and neoplastic growth
20. The IGF-1 receptor in cell growth, transformation and apoptosis
21. Mutant IGF-1 receptors as dominant negatives for growth and transformation
22. Induction of tumor suppression and glandular differentiation of A549 lung carcinoma cells by dominant-negative IGF-1 receptor
23. Inhibition of tumor growth by a dominant negative mutant of the insulin-like growth factor 1 receptor with a bystander effect
24. Simian virus 40 large tumor antigen is unable to transform mouse embryonic fibroblasts lacking type-1 IGF receptor
25. Inhibition of PDGF β receptor signal transduction by co-expression of a truncated receptor
26. Versatile retroviral vectors for potential use in gene therapy
27. Self-inactivating retroviral vectors designed for transfer of whole genes into mammalian cells
28. Role of the promoter in the regulation of the thymidine kinase gene
29. Insulin-like growth factor 1 receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity
30. Efficient in vitro and in vivo gene regulation of a retrovirally-delivered pro-apoptotic factor under the control of the Drosophila HSP70 promoter
31. Constitutive expression of insulin-like growth factor 1 and insulin-like growth factor 1 receptor abrogates all requirements for exogenous growth factors
32. The IGF-1 receptor in mitogenesis and transformation of mouse embryo cells: Role of receptor number
33. Insulin-like growth factor 1 receptor signaling in transformation by src oncogene
34. Different effects on mitogenesis and transformation of a mutation at tyrosine 1251 of the insulin-like growth factor 1 receptor
35. Synthetic peptide sequence from the C-terminus of the insulin-like growth factor 1 receptor that induces apoptosis and inhibition of tumor growth
36. Effect of a null mutation of the type 1 IGF receptor gene on growth and transformation of mouse embryo fibroblasts
37. Mice carrying null mutations of the genes encoding insulin-like growth factor 1 (igf- 1) and type 1 IGF receptor (Igflr)
38. Role of insulin-like growth factors in embryonic and postnatal growth
39. The granulin/epithelin precursor abrogates the requirement for the insulin-like growth factor 1 receptor for growth in vitro
40. Sequence organization of two recombinant plasmids containing genes for the major heat-shock induced protein of D. melanogaster
41. Disruption of epithelial cell-matrix interactions induces apoptosis
42. Control of adhesion-dependent cell survival by focal adhesion kinase
43. Inhibition of hamster mesothelioma tumorigenesis by an antisense expression plasmid to the insulin-like growth factor 1 receptor
44. Interference of the IGF system as a strategy to inhibit breast cancer growth
45. In vivo treatment with antibody against the IGF-1 receptor suppresses growth of human rhabdomyosarcoma and down regulates p34/cdc2
46. The IGF-1 receptor domains for protection from apoptosis are distinct from those required for proliferation and transformation
47. Expression of the IGF-1 receptor C-terminus as a myristylated protein leads to induction of apoptosis in tumor cells
48. Inhibition of tumorigenesis and induction of apoptosis in human tumor cells by the stable expression of a myristylated COOH terminus of the insulin-like growth factor 1 receptor
49. The eS-Sence of-SH in the ER
50. Insulin-like growth factors (IGFs) and IGF binding protein-3 display disulfide isomerase activity